Actinium Pharmaceuticals ...

AMEX: ATNM · Real-Time Price · USD
1.69
0.04 (2.42%)
At close: Aug 15, 2025, 3:59 PM
1.69
0.00%
After-hours: Aug 15, 2025, 05:56 PM EDT

Actinium Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-38.24M -48.82M -33.02M -24.77M
Depreciation & Amortization
811K 790K 699K 524K
Stock-Based Compensation
5.29M 3.84M 2.79M 1.69M
Other Working Capital
-545K -972K 33.57M 495K
Other Non-Cash Items
n/a n/a -402K 1.55M
Deferred Income Tax
n/a n/a 402K -1.55M
Change in Working Capital
-932K -3.15M 38.17M 1.69M
Operating Cash Flow
-33.07M -47.34M 8.64M -20.87M
Capital Expenditures
-11K -153K -366K -133K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
-11K -153K -366K -133K
Debt Repayment
-9K -4K -49K -85K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
75K n/a n/a 6K
Financial Cash Flow
29.32M 14.87M 23.11M 35.22M
Net Cash Flow
-3.76M -32.62M 31.39M 14.22M
Free Cash Flow
-33.08M -47.49M 8.28M -21M